1.Clinical Significance of White Bile (Bilirubin-Free Bile) in Malignant Bile Duct Obstruction.
Jin Tae JUNG ; Ho Gak KIM ; Jimin HAN ; Joong Goo KWON ; Chang Hyeong LEE ; Eun Young KIM
The Korean Journal of Gastroenterology 2008;52(2):91-96
BACKGROUND/AIMS: White bile is colorless, translucent fluid found occasionally in malignant bile duct obstruction (MBO). Little information is available on the cause and effect of white bile. The aim of this study was to determine the frequency and clinical significance of white bile in MBO. METHODS: Bile was aspirated during endoscopic retrograde cholangiopancreatography in consecutive patients with MBO. White bile was defined as bile bilirubin <1.5 mg/dL and yellow bile was defined as bile bilirubin >or=1.5 mg/dL in the bile. Two groups were compared prospectively for the duration of jaundice, itching, cholangitis, level of obstruction, and decremental rate of bilirubin after the insertion of 7 Fr endoscopic nasobiliary drainage until the insertion of metal stent or 10 Fr plastic stent. RESULTS: Among 60 patients with MBO, 16 (26.7%) had white bile. WBC count in blood was higher (9,456/mm3 vs. 7,400/mm3, p=0.029) and cholangitis was more common (11/16 vs. 7/44, p=0.000) in white than yellow bile group. Proximal portion of MBO had no communication with GB in 9/16 patients with white bile group and 17/44 patients with yellow bile group (p>0.05). Mean survival of the inoperable 35 patients was 242 days in yellow bile and 227 days in white bile group (p>0.05). CONCLUSIONS: White bile in MBO was not rare and was associated with cholangitis. Gallbladder did not seem to play a role in the formation of white bile. Further study for the pathogenesis and prognosis of white bile in MBO will be necessary.
Aged
;
Bile/*chemistry/microbiology
;
Bile Duct Neoplasms/*diagnosis/etiology/mortality
;
Bilirubin/analysis
;
Cholangiopancreatography, Endoscopic Retrograde
;
Cholangitis/diagnosis/etiology/mortality
;
Cholestasis/*diagnosis/etiology/mortality
;
Data Interpretation, Statistical
;
Drainage
;
Female
;
Humans
;
Male
;
Middle Aged
;
Stents
;
Survival Analysis
2.Changes in Causative Pathogens of Acute Cholangitis and Their Antimicrobial Susceptibility over a Period of 6 Years.
Jeong Seok KWON ; Jimin HAN ; Tae Won KIM ; Ji Hye OH ; Hyun Hee KWON ; Jin Tae JUNG ; Joong Goo KWON ; Eun Young KIM ; Ho Gak KIM
The Korean Journal of Gastroenterology 2014;63(5):299-307
BACKGROUND/AIMS: We evaluated changes of causative pathogen in acute cholangitis and their antimicrobial susceptibility over six years and differences between community-acquired and hospital-acquired acute cholangitis at our institution. METHODS: Medical records of 1,596 patients with acute cholangitis and biliary drainage between August 2006 and August 2012 were reviewed retrospectively. Cases were divided according to time: period 1 (August 2006-December 2008, n=645, 40.4%), period 2 (January 2009-August 2012, n=951, 59.6%). Cases were divided according to community-acquired cholangitis (n=1,397, 87.5%) and hospital-acquired cholangitis (n=199, 12.5%). Causative pathogens and antimicrobial susceptibility were investigated in each group. RESULTS: Causative pathogen was isolated from bile culture in 1,520 out of 1,596 cases (95.2%). The three most frequently isolated Gram-negative bacteria were extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (n=485, 30.4%), E. coli (n=237, 13.2%), and Citrobacter freundii (n=110, 6.9%). Between periods 1 and 2, prevalence of ESBL-producing E. coli and Klebsiella pneumoniae did not show significant change (36.7% vs. 32.1%, p=0.073; 6.6% vs. 6.2%, p=0.732). C. freundii showed a significant increase from period 1 to period 2 (1.7% vs. 13.2%, p=0.000). In both time periods, imipenem was the antimicrobial agent showing the highest rate of susceptibility (93.3% vs. 93.9%, p=0.783). Higher prevalence of ESBL-producing E. coli and C. freundii was observed in the hospital-acquired cholangitis group (52.1% vs. 31.2%, p=0.000; 15.9% vs. 7.3%, p=0.001). CONCLUSIONS: The most common causative pathogen of acute cholangitis was ESBL-producing E. coli. Prevalence of C. freundii increased over the time period. Imipenem should be reserved as an alternative for resistant pathogens.
Acute Disease
;
Aged
;
Aged, 80 and over
;
Anti-Bacterial Agents/*pharmacology
;
Cholangitis/diagnosis/*microbiology
;
*Citrobacter freundii/drug effects/isolation & purification
;
Community-Acquired Infections/microbiology
;
Cross Infection/microbiology
;
Drug Resistance, Bacterial
;
*Escherichia coli/drug effects/isolation & purification
;
Female
;
Humans
;
Imipenem/pharmacology
;
*Klebsiella pneumoniae/drug effects/isolation & purification
;
Male
;
Microbial Sensitivity Tests
;
Middle Aged
;
Retrospective Studies
;
Time Factors
;
beta-Lactamases/metabolism